News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major news items published in the past hour.
  • No significant economic data or central bank announcements were released in the past hour.
  • No new geopolitical events or conflict escalations reported in the past hour.
  • No material corporate earnings or M&A headlines appeared in the past hour.
  • Markets lacked headline catalysts and traded with subdued volume during the hour.
  • No regulatory or policy shifts were announced in the past hour.

Latest Articles

Moonshot AI Weighs Hong Kong Listing, Could Seek Up to $5 Billion

Moonshot AI Weighs Hong Kong Listing, Could Seek Up to $5 Billion

Moonshot AI, a Beijing-based artificial intelligence laboratory, has confidentially filed for an initial public offering in Hong Kong and is considering raising between $3 billion and $5 billion. The company has added Bank of America as overall coordinator alongside China International Capital Corp., Deutsche Bank and Goldman Sachs. Moonshot recent…

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

Nano-X Imaging Ltd. (NASDAQ: NNOX) announced a new distribution agreement between its U.S. subsidiary, Nanox Impact Inc., and Associated X-Ray Imaging Corp., a leading New England medical imaging provider. This partnership will leverage Associated X-Ray's regional presence to market, distribute, and support Nanox's FDA-cleared digital 3D tomosynthe…

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

Tarsus Pharmaceuticals has completed its acquisition of Alkeus Pharmaceuticals, gaining worldwide rights to ALK-001, a Phase 3 investigational oral drug targeting Stargardt disease, a rare retinal disorder with no FDA-approved treatments. ALK-001 has several FDA designations including Breakthrough Therapy and Orphan Drug, and topline Phase 3 data f…

Canada’s Labour Market Cools as August Sees 41,700 Jobs Lost

Canada’s Labour Market Cools as August Sees 41,700 Jobs Lost

Canada shed 41,700 positions in August, driven primarily by losses in full-time work and concentrated declines across service-producing industries. The unemployment rate remained unchanged at 6.4% even as hourly wage growth slowed and the labour force contracted for the first time since February. The report arrives just before higher U.S. tariffs a…

Virco Reports Revenue through Six Months Declined 6.1% to $118.2 Million from $125.8 Million, as Rebalancing of School Furniture Market Continues

Virco Reports Revenue through Six Months Declined 6.1% to $118.2 Million from $125.8 Million, as Rebalancing of School Furniture Market Continues

Virco Mfg. Corporation reported a 6.1% decline in revenue through the first six months of 2026 to $118.2 million, reflecting ongoing market rebalancing in the school furniture sector. Despite lower sales, the company maintained strong operating income above its long-term average and declared a quarterly dividend. Recent budget approvals in public s…

Morgan Stanley Elevates Accor, Keeps IAG as Top European Travel Picks on Demand Recovery and Cash Returns

Morgan Stanley Elevates Accor, Keeps IAG as Top European Travel Picks on Demand Recovery and Cash Returns

Morgan Stanley has added Accor to its European travel and leisure Top Picks list and retained IAG, upgrading Accor to overweight and keeping IAG at overweight. The broker raised Accor’s price target to €55 and maintained IAG’s at €5.80, each implying roughly 18% upside, while highlighting expected cash returns, buybacks and structural revenue impro…

McDonald’s Near Two-Year Lows, But Technicals and Valuation Give Pause

McDonald’s Near Two-Year Lows, But Technicals and Valuation Give Pause

McDonald’s shares are trading near their 52-week low, yet technical indicators across daily, weekly and monthly horizons remain in Strong Sell territory. While revenue growth and margins show durability, valuation and execution questions constrain the upside. The stock is better suited for a watchlist until price action stabilizes and momentum impr…

NANO Nuclear Energy and Enveniam Sign Memorandum of Understanding to Advance U.S. Nuclear Fuel Cycle, Microreactor Deployment and Energy Infrastructure

NANO Nuclear Energy and Enveniam Sign Memorandum of Understanding to Advance U.S. Nuclear Fuel Cycle, Microreactor Deployment and Energy Infrastructure

NANO Nuclear Energy Inc., a Nasdaq-listed advanced nuclear technology company, announced a non-binding Memorandum of Understanding with Enveniam to explore collaboration on nuclear fuel transportation, conversion, microreactor commercialization, advanced manufacturing, and energy solutions for data centers and remote communities. The partnership ai…

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

Rein Therapeutics announced it will present a late-breaking poster on LTI-03, its novel inhaled peptide therapy for idiopathic pulmonary fibrosis, at the European Respiratory Society (ERS) 2026 Congress. The presentation will detail data from the RENEW Phase 2 trial evaluating safety and efficacy of LTI-03, which aims to inhibit lung fibrosis and p…

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms

Nautilus Biotechnology announced a pioneering peer-reviewed study published in Nature Methods demonstrating its Iterative Mapping technology's ability to quantify distinct tau proteoforms at single-molecule resolution. This novel measurement reveals disease-associated ordered modification patterns crucial for understanding Alzheimer's disease and r…

Hurco Reports Profit in Third Quarter Results for Fiscal Year 2026

Hurco Reports Profit in Third Quarter Results for Fiscal Year 2026

Hurco Companies, Inc. reported a net income of $2.314 million for Q3 fiscal 2026, a significant turnaround from a net loss in the same period last year. Sales increased 3% year-over-year, driven by higher machine sales in the U.S. and Asia Pacific regions and a stronger product mix. Gross margin expanded by 800 basis points to 28%, aided by cost co…

Alumis to Participate in Upcoming September Investor Conferences

Alumis to Participate in Upcoming September Investor Conferences

Alumis Inc., a late-stage biopharmaceutical company specializing in next-generation targeted therapies for immune-mediated diseases, announced its participation in several prominent investor conferences throughout September 2026. The company plans to present updates on its pipeline, including oral TYK2 inhibitors envudeucitinib and A-005, targeting…